Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study

Journal of the American Heart Association

  ^{1    1    1    1    1    1    1    2    3    4    4    5    6    7    8    9} 

[1] Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea;Department of Cardiology in Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea;Department of Cardiovascular Medicine, Medical School of Chonbuk National University, Jeonju, Korea;Department of Internal Medicine, Chonnam National University Hospital, Kwangju, Korea;Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea;Department of Internal Medicine, Kyunghee University Hospital, Seoul, Korea;Department of Internal Medicine, Kyungpook National University Hosptial, Daegu, Korea;Department of Internal Medicine, Seoul National University Bundang Hospital, Sungnam, Korea;Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea;

关键词: acute myocardial infarction;    beta‐blocker;    cohort study;    prognosis;    propensity score;   

DOI  :  10.1161/JAHA.117.007063

来源: publisher

【 授权许可】

Unknown